Reviewed by Michael Gill, B. Sc.
1 Acoustic Neuroma Clinical Trials Near Me
Top Hospitals for Acoustic Neuroma Clinical Trials
Image of University of California Los Angeles in California.
University of California Los Angeles
Los Angeles
1Active Trials
1All Time Trials for Acoustic Neuroma
2015First Acoustic Neuroma Trial
Top Cities for Acoustic Neuroma Clinical Trials
Image of Los Angeles in California.
Los Angeles
1Active Trials
University of California Los AngelesTop Active Site
Acoustic Neuroma Clinical Trials by Phase of Trial
Phase 2 Acoustic Neuroma Clinical Trials
1Active Acoustic Neuroma Clinical Trials
1Number of Unique Treatments
0Number of Active Locations
Acoustic Neuroma Clinical Trials by Age Group
Any Age Acoustic Neuroma Clinical Trials
1Active Acoustic Neuroma Clinical Trials
Most Recent Acoustic Neuroma Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Top Treatments for Acoustic Neuroma Clinical Trials
Treatment Name
Active Acoustic Neuroma Clinical Trials
All Time Trials for Acoustic Neuroma
First Recorded Acoustic Neuroma Trial
RAD001, everolimus
1
1
2015

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 5th, 2021

Last Reviewed: October 3rd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Goutagny S, Raymond E, Esposito-Farese M, Trunet S, Mawrin C, Bernardeschi D, Larroque B, Sterkers O, Giovannini M, Kalamarides M. Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas. J Neurooncol. 2015 Apr;122(2):313-20. doi: 10.1007/s11060-014-1710-0. Epub 2015 Jan 8. https://pubmed.ncbi.nlm.nih.gov/255673522 Giovannini M, Bonne NX, Vitte J, Chareyre F, Tanaka K, Adams R, Fisher LM, Valeyrie-Allanore L, Wolkenstein P, Goutagny S, Kalamarides M. mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma. Neuro Oncol. 2014 Apr;16(4):493-504. doi: 10.1093/neuonc/not242. Epub 2014 Jan 10. https://pubmed.ncbi.nlm.nih.gov/24414536